• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Trimetazidine Dihydrochloride

Trimetazidine Dihydrochloride

Product ID T7133
Cas No. 13171-25-0
Purity ≥99%
Product Unit SizeCostQuantityStock
250 mg $52.50 In stock
1 g $84.00 In stock
5 g $131.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Trimetazidine is a compound that exhibits anti-anginal, anti-ischemic, and cardioprotective activities; it inhibits long-chain 3-ketoacyl-CoA thiolase. Trimetazidine reverses pro-inflammatory effects of TNF-α in animal models, including preventing decreases in myosin heavy chain production and myotube size. Trimetazidine prevents muscle wasting and atrophy; its mechanism may involve activation of Akt/mTOR2 signaling. In animal models of ischemia/reperfusion, trimetazidine decreases superoxide generation and caspase-3 activity, decreasing infarct size. In clinical settings, this compound decreases free fatty acid oxidation, improving cardiac function, insulin sensitivity, and glucose control. Trimetazidine also treats vertigo and may act as an antagonist at kainate and AMPA receptors.

Product Info

Cas No.

13171-25-0

Purity

≥99%

Formula

C14H22N2O3•2HCl

Formula Wt.

339.26

Chemical Name

1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride

IUPAC Name

1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride

Synonym

Trimetazidine Hydrochloride

Appearance

White Odorless Crystalline Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

T7133 MSDS PDF

Info Sheet

T7133 Info Sheet PDF

References

Ferraro E, Giammarioli AM, Caldarola S, et al. The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes. FEBS J. 2013 Oct;280(20):5094-108. PMID: 23953053.

Khan M, Meduru S, Mostafa M, et al. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther. 2010 May;333(2):421-9. PMID: 20167841.

Tuunanen H, Engblom E, Naum A, et al. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy. Circulation. 2008 Sep 16;118(12):1250-8. PMID: 18765391.

Dayanithi G, Desmadryl G, Travo C, et al. Trimetazidine modulates AMPA/kainate receptors in rat vestibular ganglion neurons. Eur J Pharmacol. 2007 Nov 21;574(1):8-14. PMID: 17658512.

Demaison L, Fantini E, Sentex E, et al. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol. 1995 Aug 24;76(6):31B-37B. PMID: 7645525.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T6834

    Triacsin C

    Acyl-CoA synthetase inhibitor.

    ≥95%
  • A5001

    Aminopterin

    Folic acid analog, derivative of pterin; dihydr...

    ≥98%
  • L582694

    Lorlatinib

    Third generation macrocyclic ALK inhibitor.

    ≥98%
  • E6376

    Eptifibatide

    Glycoprotein IIb/IIIa inhibitor.

    ≥98%
  • N4524

    NLG919

    Indoleamine-2,3-dioxygenase inhibitor.

    ≥98%
  • E6396

    EPZ005687

    EZH2 HMT inhibitor.

    ≥99%
  • B5000

    BMS-911543

    JAK2 inhibitor.

    ≥99%
  • C0351

    Carprofen

    NSAID; COX-2 inhibitor.

    ≥98%
  • C3210

    Ciglitazone

    Thiazolidinedione; PPARγ agonist.

    ≥98%
  • G0145

    Gallic Acid

    Phenol found in various plant sources, used to ...

    ≥98%
  • E7376

    Estradiol

    Endogenous steroid hormone, involved in regulat...

    ≥97%
  • P7103

    Praziquantel

    Alters membrane permeability and Ca2+ signaling...

    ≥98%
  • I6932

    Irinotecan

    Camptothecin analog; topoisomerase I inhibitor,...

    ≥98%
  • T3584

    Tivantinib

    MET and GSK-3α/β inhibitor.

    ≥98%
  • H2980

    Humanin, human

    Endogenous peptide; FPRL1/2 agonist.

    ≥95%
  • C7098

    Crystalline peptide

    Dipeptide.

    ≥95%
  • T2932

    Thiamphenicol Glycinate Hydrochloride

    Chloramphenicol derivative; protein translation...

    ≥98%
  • N0061

    D-Naproxen

    NSAID; COX-1/2 inhibitor.

    ≥99%
  • P2845

    Phleomycin

    Glycopeptide, metal ion chelator, induces DNA s...

    ≥97%
  • P327212

    Pifithrin-α-cyclic Hydrobromide

    p53 inhibitor

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only